Ensuring the persistence of immune memory

Time-lapse photography at two-minute intervals shows the migration (white trail) of a Bcl6-expressing B cell (green) into the GC (blue) following induction of an immune response (top). By comparison, B cells with inhibited Bcl6 function fail to migrate to the GC (bottom). Credit: Ref. 1 © 2011 Elsevier, Inc

Structures within the lymph nodes known as germinal centers (GCs) help the body to maintain long-term immune defense against foreign threats. The GCs essentially act as sites where antibody-producing B cells undergo a process of ‘evolution’ to generate higher-quality antibodies. This evolutionary mechanism is in turn supported by a class of T cells known as follicular helper T (Tfh) cells.

Takaharu Okada and colleagues at the RIKEN Research Center for Allergy and Immunology in Yokohama recently tracked the process of B cell development in mouse GCs by monitoring expression of Bcl61. This protein facilitates B cell evolution by regulating expression of key developmental genes.

The researchers were surprised to note a broader scope of Bcl6 activity than expected. “It became apparent that Bcl6 is important for Tfh cells as well,” says Okada, “and I felt that we should track [the levels of] Bcl6 expression in both B and T cells at the same time.”

They quantified Bcl6 levels by generating transgenic mice in which a DNA fragment encoding a fluorescent protein had been inserted into one copy of the Bcl6 gene. Since this insertion partially disrupted Bcl6 function, this reporter system enabled the researchers to examine the effects of inhibiting this protein.

Following the induction of an immune response in the animals, Okada and colleagues observed an increase of Bcl6 expression in antigen-specific within peripheral regions of the lymph node; these subsequently migrated to the GC, where they continued to strongly express Bcl6 (Fig. 1).

This migration and maturation process is dependent upon interaction with Bcl6-expressing helper T cells. All T cells expressing high levels of Bcl6 became Tfh cells, but many Tfh cells subsequently reduced Bcl6 production to varying degrees. Okada was surprised that the dynamics of Bcl6 expression differed between B and T cells. “This suggests that they employ different mechanisms for regulating expression of this important transcription factor,” he says.

Okada and his team also recorded observations suggesting that Tfh cells expressing low levels of Bcl6 may give rise to ‘memory cells’, which enable the immune system to react quickly to recurring threats. However, this will require further investigation.

Understanding how these various cells employ this shared regulatory factor will also be a top priority moving forward. “We would like to learn the molecular mechanisms of Bcl6 expression in B and T by setting up collaborations with experts in the field of gene and protein expression control,” says Okada.

More information: Kitano, M., et al. Bcl6 protein expression shapes pre-germinal center B cell dynamics and follicular helper T cell heterogeneity. Immunity 34, 961–972 (2011)

add to favorites email to friend print save as pdf

Related Stories

Bcl6 gene sculpts helper T cell to boost antibody production

Jul 23, 2009

Expression of a single gene programs an immune system helper T cell that fuels rapid growth and diversification of antibodies in a cellular structure implicated in autoimmune diseases and development of B cell lymphoma, scientists ...

Small molecule targets B cell lymphoma

Apr 12, 2010

Scientists are one step closer to developing a targeted therapy for lymphoma. New research, published by Cell Press in the April 13th issue of the journal Cancer Cell, identifies a specific small-molecule inhibitor that w ...

Genetic trigger for disease-fighting antibodies discoverd

Jul 16, 2009

A research team led by the La Jolla Institute for Allergy & Immunology has identified the specific gene which triggers the body to produce disease-fighting antibodies -- a seminal finding that clarifies the exact molecular ...

Recommended for you

Researcher studies protein's link to heart disease

Jun 18, 2013

(Medical Xpress)—The largest protein known to exist in the human body functions as a molecular spring, and University of Arizona researchers are gaining new insights into its role in heart disease.

The rhythm of everything

Jun 18, 2013

Dawn triggers basic biological changes in the waking human body. As the sun rises, so does heart rate, blood pressure and body temperature. The liver, the kidneys and many natural processes also begin shifting ...

User comments

More news stories

Laughing gas does not increase heart attacks

(Medical Xpress)—Nitrous oxide—best known as laughing gas—is one of the world's oldest and most widely used anesthetics. Despite its popularity, however, experts have questioned its impact on the risk ...

Model recreates wear and tear of osteoarthritis

(Medical Xpress)—There's a reason osteoarthritis is often called wear-and-tear arthritis: Repeated stress on joints over time results in degeneration of the soft cartilage that normally distributes loads ...

Taxing unhealthy food spurs people to buy less

Labeling foods and beverages as less-healthy and taxing them motivates people to make healthier choices, finds a recent study in the American Journal of Preventive Medicine. When faced with a 30 percent tax on ...

Renewed hope in a once-abandoned cancer drug class

Could drugs that block the body's system for repairing damage to the genetic material DNA become a boon to health? As unlikely as it may seem, those compounds are sparking optimism as potential treatments ...

New technologies for retinal therapies

The future of the investigation and treatment of retinal disorders is already here at the MedUni Vienna: in the new Christian Doppler "OPTIMA" (Ophthalmic Image Analysis) laboratory headed by Ursula Schmidt-Erfurth, ...

Protalix signs supply deal with Brazilian govt

Shares of Protalix BioTherapeutics Inc. jumped in premarket trading Wednesday after the drug developer announced a deal that requires the Brazilian government to buy at least $280 million of the company's Gaucher disease ...